Prostate neuroendocrine carcinoma successfully treated with etoposide and cisplatin
Introduction The frequency of neuroendocrine carcinoma of the prostate is low, accounting for approximately 1%–5% of all prostate cancers. Herein, we report the case of a patient who was diagnosed with prostate neuroendocrine carcinoma and successfully treated with etoposide and cisplatin. Case pres...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2024-11-01
|
| Serie: | IJU Case Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/iju5.12787 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|